Circulating Proteins Associated with Response and Resistance to Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer

Circulating Proteins Associated with Response and Resistance to Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer

Despite the increasing use of neoadjuvant chemotherapy (NAC) in HER2-positive breast cancer (BC) patients, the clinical problem of predicting individual treatment response remains unanswered. Furthermore, the use of ineffective chemotherapeutic regimens should be avoided. Serum biomarker levels are...

Full description

Bibliographic Details
Main Authors: María del Pilar Chantada-Vázquez, Mercedes Conde-Amboage, Lucía Graña-López, Sergio Vázquez-Estévez, Susana B. Bravo, Cristina Núñez
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Cancers
Subjects:
breast cancer
HER2-positive
neoadjuvant
predictive
biomarkers
proteomics
Online Access:https://www.mdpi.com/2072-6694/14/4/1087

Internet

https://www.mdpi.com/2072-6694/14/4/1087

Similar Items